Related Experiment Video
Updated: Jun 8, 2026

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
Published on: December 15, 2017
Engineering homoserine kinase for competitive inhibition release to enhance l-threonine production in Corynebacterium
Guihong Zhao1, Yaqun Tang1, Dezhi Zhang1
1State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, China; Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi 214122, China.
Abstract:
l-threonine is widely used in the food, pharmaceutical, cosmetic, and feed industries. However, the activity of homoserine kinase (HK) in Corynebacterium glutamicum is competitively inhibited by l-threonine, restricting the efficient production of l-threonine. To address this inhibition, we identified a critical residue Arg212 and subsequently generated an optimal mutant R212Q via site-directed saturation mutagenesis. Kinetic characterization revealed that the HKR212Q variant exhibited both enhanced binding affinity for l-homoserine and a 2-fold improvement in catalytic efficiency. Molecular docking simulations demonstrated that the mutated substrate-binding pocket sterically hindered l-threonine binding while accommodating l-homoserine. Further mechanistic insights were obtained through molecular dynamics simulations, which uncovered ligand selectivity determinants mediated by dynamic flexibility changes in three functional regions. Finally, we achieved 86.4 g/L of l-threonine with a yield of 0.28 g/g glucose by overexpressing the efflux transporter ThrE in the engineered strain R212Q/pXTuf-thrE, representing the highest l-threonine production to date. The Arg212 residue identified in this study represents the first characterized site capable of relieving competitive inhibition in HK family. The mechanistic elucidation provides valuable insights for engineering other kinase-family proteins to overcome similar metabolic constraints.
Related Concept Videos
Bioreactor Controls-III
Production of Antibiotics
Production of Pharmaceuticals

